P. Mohr

FC09.05 Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia

P. Czobor, J. McEvoy, J. Volavka, 2000, European Psychiatry.

Prevalence of psychotic-like experiences in healthy adolescents: Preliminary data and educational program for high schools

P. Knytl, V. Voráčková, P. Mohr, 2018, European Neuropsychopharmacology.

S-Ketamine Oral Thin Film—Part 1: Population Pharmacokinetics of S-Ketamine, S-Norketamine and S-Hydroxynorketamine

A. Dahan, E. Olofsen, M. Niesters, 2022, Frontiers in Pain Research.

S-Ketamine oral thin film—Part 2: Population pharmacodynamics of S-ketamine, S-norketamine and S-hydroxynorketamine

A. Dahan, E. Olofsen, M. Niesters, 2022, Frontiers in Pain Research.

White matter changes in first episode psychosis and their relation to the size of sample studied: A DTI study

J. Hlinka, F. Španiel, J. Horáček, 2015, Schizophrenia Research.

Repetitive transcranial magnetic stimulation and rehabilitation of cognitive functions in schizophrenia

M. Kopeček, R. Záleský, J. Horáček, 2007, European Psychiatry.

P0363 - Asymmetry of language activation in families with multiple incidence of schizophrenia

F. Španiel, P. Mohr, J. Čermák, 2008, European Psychiatry.